Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Bain Capital’s $250 Million Minority Investment in Sikich
Kirkland & Ellis and Hunton Andrews Kurth advised Bain Capital LP on the transaction, while Holland & Knight and Vedder Price advised Sikich LLC. Sikich LLC,...
Ares Management’s $1.08 Billion Acquisition of Landmark Partners
Ropes & Gray represented BrightSphere Investment Group, Inc. and Landmark Partners, LLC, while Kirkland & Elis LLP represented Ares on the deal. Ares Management Corporation (“Ares”)...